I think we made a choice in the 1970s to promote a generic pharmaceutical industry. It's a choice that has an obvious consequence. I know some of you on the panel are lawyers. If you look at the list of cases on the docket of the Federal Court of Canada, you'll find that there are an awful lot of cases that start with the letter A, because the company with the letter A—
On April 23rd, 2021. See this statement in context.